Is It Time To Buy BMY Stock?

Bristol-Myers Squibb (NYSE: BMY) stock merits your attention. Why? Because it offers high margins at a discounted price. Here are some details.Revenue Growth: Bristol-Myers Squibb experienced a growth of 4.6% LTM and an average of 0.5% over the last three years.Recent Profitability: Approximately 30.0% operating cash flow margin and 16.5% operating margin LTM.Long-Term Profitability: About 28.9% operating cash flow margin and 17.3% operating margin average for the last three years.Available At Discount: Cu ...